The role of NF-κB in hypoxia-induced gene expression

Annals of the New York Academy of Sciences

Volumn 1177, Issue , 2009, Pages 178-184

  Taylor, Cormac T ^a   Cummins, Eoin P ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Hypoxia; Hypoxia inducible factor (HIF); Inflammation; Nuclear factor kappaB (NF B)

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; HYPOXIA INDUCIBLE FACTOR 1;

APOPTOSIS; CONFERENCE PAPER; GENE EXPRESSION; INNATE IMMUNITY; NONHUMAN; OXYGEN SENSING; ANIMAL; ANOXIA; BIOLOGICAL MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; ANOXIA; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MODELS, BIOLOGICAL; NF-KAPPA B;

EID: 70350373671     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05024.x     Document Type: Conference Paper

References (34)

1. Kerr, R.A. 2005. Earth science. The story of O2. Science 308: 1730-1732.
2. Semenza, G.L. 2007. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE 2007: cm8.
3. Kaelin,W.G., Jr. & P.J. Ratcliffe. 2008. Oxygen sensing bymetazoans: the central role of theHIF hydroxylase pathway. Mol. Cell. 30: 393-402.
4. Cummins, E.P. & C.T. Taylor. 2005. Hypoxiaresponsive transcription factors. Pflugers. Arch. 450: 363-371.
5. Karin, M. 2008. The IkappaB kinase-a bridge between inflammation and cancer. Cell Res. 18: 334-342.
6. Hayden, M.S. & S. Ghosh. 2008. Shared principles in NF-kappaB signaling. Cell 132: 344-362.
7. Moynagh, P.N. 2005. The NF-{kappa}B pathway. J. Cell. Sci. 118: 4589-4592.
8. Senftleben, U. et al. 2001. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293: 1495-1499.
9. Karin, M. 2006. Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436.
10. Doyle, S.L. & L.A. O'Neill. 2006. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem. Pharmacol. 72: 1102-1113.
11. Han, Y.P., T.L. Tuan, H.Wu, et al. 2001. TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1- MMP. J. Cell. Sci. 114: 131-139.
12. Greten, F.R. et al. 2004. IKKbeta links inflammation and tumorigenesis in a mouse model of colitisassociated cancer. Cell 118: 285-296.
13. Neurath, M.F. et al. 1998. Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease. Ann. N. Y. Acad. Sci. 859: 149-159.
14. Schreiber, S., S. Nikolaus & J. Hampe. 1998. Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42: 477-484.
15. Feldmann, M., F.M. Brennan & R.N. Maini. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14: 397-440.
16. Roman-Blas, J.A. & S.A. Jimenez. 2008. Targeting NF-kappaB: A promising molecular therapy in in- flammatory arthritis. Int. Rev. Immunol. 27: 351-374.
17. Oliver K.M., T.C. Taylor & E.P. Cummins. 2009. Hypoxia. Regulation of NFαB signaling during in- flammation: the role of hydroxylases. Arthritis Res. Ther. 11: 215.
18. Koong, A.C., E.Y. Chen & A.J. Giaccia. 1994. Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res. 54: 1425-1430.
19. Schmedtje, J.F., Jr., Y.S. Ji, W.L. Liu, et al. 1997. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem. 272: 601-608.
20. Taylor, C.T., A.L. Dzus & S.P. Colgan. 1998. Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor alpha. Gastroenterol. 114: 657-668.
21. Matsui, H. et al. 1999. Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-kappa B and NF-IL6 in cardiac myocytes. Cardiovasc. Res. 42: 104-112.
22. Zampetaki, A., S.A. Mitsialis, J. Pfeilschifter & S. Kourembanas. 2004. Hypoxia induces macrophage inflammatory protein-2 (MIP-2) gene expression in murine macrophages via NF-kappaB: the prominent role of p42/p44 and PI3 kinase pathways. Faseb J. 18: 1090-1092.
23. Cummins, E.P., E. Berra, K.M. Comerford, et al. 2006. Prolyl hydroxylase-1 negatively regulates IkB kinase-beta giving insight into hypoxia-induced NFkB activity. Proc. Natl. Acad. Sci. USA.
24. Cockman, M.E. et al. 2006. Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proc. Natl. Acad. Sci. USA 103: 14767-14772.
25. Rius, J. et al. 2008. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453: 807-811.
26. Belaiba, R.S. et al. 2007. Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol. Biol. Cell. 18: 4691-4697.
27. van Uden, P., N.S. Kenneth & S. Rocha. 2008. Regulation of hypoxia-inducible factor-1alpha by NFkappaB. Biochem. J. 412: 477-484.
28. Walmsley, S.R. et al. 2005. Hypoxia-induced neutrophil survival is mediated by HIF-1alphadependent NF-kappaB activity. J. Exp. Med. 201: 105-115.
29. Taylor, C.T. 2008. Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J. Physiol. 586: 4055-4059.
30. Taylor, C.T. & S.P. Colgan. 2007. Hypoxia and gastrointestinal disease. J. Mol. Med. 85: 1295-1300.
31. Karhausen, J. et al. 2004. Epithelial hypoxiainducible factor-1 is protective in murine experimental colitis. J. Clin. Invest. 114: 1098-1106.
32. Cummins, E.P. et al. 2008. The hydroxylase inhibitor dimethyloxalylglycine is protective in amurine model of colitis. Gastroenterol. 134: 156-165.
33. Robinson, A. et al. 2008. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterol. 134: 145-155.
34. Fraisl, P., J. Aragones & P. Carmeliet. 2009. Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat. Rev. Drug Discov. 8: 139-152.